FibroGen Announces Positive Type C Meeting With The FDA For Roxadustat In Patients With Anemia Associated With Lower-Risk Myelodysplastic Syndromes
RefinitivOkuma süresi: 1 dakikadan kısa
FibroGen Inc 
FGEN:
FIBROGEN ANNOUNCES POSITIVE TYPE C MEETING WITH THE FDA FOR ROXADUSTAT IN PATIENTS WITH ANEMIA ASSOCIATED WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES
Bu haberi okumak için giriş yapın veya sonsuza kadar ücretsiz bir hesap oluşturun